Would You Like To Book A SmartState Program Speaker?

Click Here

Dr. Patrick Woster

Endowed Chair in Medicinal Chemistry 

Cancer Drug Discovery
CENTER OF ECONOMIC EXCELLENCE

  • Leading cancer drug researcher
  • Developing cancer drugs that turn specific genes in tumor cells on or off, a process known as epigenetic modulation, that can make anti-tumor medications more effective.
  • Working to discover new treatments for malaria and other parasitic illnesses.
  • Holds eight patents based on compounds he has synthesized.
  • Director, MUSC Drug Design and Synthesis Core 
  • PhD, University of Nebraska
  • Fellowship, Chemistry, Rensselaer Polytechnic Institute
  • Fellowship, Medicinal Chemistry, University of Michigan

Dr. Patrick Woster is one of the nation's leading cancer drug researchers and is working to develop drugs that turn specific genes in tumor cells on or off, a process known as epigenetic modulation that can make anti-tumor medications more effective. He and his team are working to discover new treatments for diseases such as malaria and other parasitic illnesses.

Dr. Woster also seeks to increase the number of early- and late-stage clinical trials of promising new drugs in South Carolina, which can bring new hope to patients and new business development opportunities to the state.

A prolific researcher, Dr. Woster holds eight patents based on compounds he has synthesized.He is one of four endowed chairs supported by the Cancer Drug Discovery Center, a Medical University of South Carolina (MUSC) Center. The goal is to develop a world-class drug discovery program at MUSC by providing a core facility for drug synthesis and compound development, and by leveraging the intellectual and physical assets of existing centers within MUSC, such as the Hollings Cancer Center.

 

Connect With SmartState Endowed Chairs To Learn About Their Research And Business Development Opportunities

Click Here